A phase 2 study of de-escalation in resectable, locally advanced cutaneous squamous cell carcinoma with the use of neoadjuvant Pembrolizumab - DESQUAMATE (2022-2025)
Experts
Professor
Ian Frazer
Emeritus Professor
Faculty of Health, Medicine and Behavioural Sciences
